Innate immunity cell activation in virologically suppressed HIV-infected maraviroc-treated patients

Chiara Dentone; Antonio Di Biagio; Alessia Parodi; Federica Bozzano; Paolo Fraccaro; Alessio Signori; Giovanni Cenderello; Eugenio Mantia; Giancarlo Orofino; Andrea De Maria; Gilberto Filaci; Daniela Fenoglio

doi:10.1097/QAD.0000000000000194

Innate immunity cell activation in virologically suppressed HIV-infected maraviroc-treated patients

Chiara Dentone, Antonio Di Biagio, Alessia Parodi, Federica Bozzano, Paolo Fraccaro, Alessio Signori, Giovanni Cenderello, Eugenio Mantia, Giancarlo Orofino, Andrea De Maria, Gilberto Filaci, Daniela Fenoglio

A.O.U. San Martino - IST, Istituto Nazionale Ricerca sul Cancro (GENOVA)

Research output: Contribution to journal › Article › peer-review

Abstract

This is a cross-sectional, case-control study analyzing the effect of antiretroviral therapy (ART) including or not maraviroc, on circulating monocytes and natural killer cells. Sixty-eight HIV-positive patients virologically suppressed receiving ART at least 6 months were subdivided as receiving (group 1) or not (group 2) maraviroc in their ART. Frequency of monocytes and natural killer cells, as well as their activation markers, were studied. Modulation of innate immune cells may be differently affected by combined ART.

Original language	English
Pages (from-to)	1071-1074
Number of pages	4
Journal	AIDS (London, England)
Volume	28
Issue number	7
DOIs	https://doi.org/10.1097/QAD.0000000000000194
Publication status	Published - Apr 24 2014

ASJC Scopus subject areas

Immunology and Allergy
Immunology
Infectious Diseases
Medicine(all)

Access to Document

10.1097/QAD.0000000000000194

Fingerprint Dive into the research topics of 'Innate immunity cell activation in virologically suppressed HIV-infected maraviroc-treated patients'. Together they form a unique fingerprint.

Cite this

Innate immunity cell activation in virologically suppressed HIV-infected maraviroc-treated patients. / Dentone, Chiara; Di Biagio, Antonio; Parodi, Alessia; Bozzano, Federica; Fraccaro, Paolo; Signori, Alessio; Cenderello, Giovanni; Mantia, Eugenio; Orofino, Giancarlo; De Maria, Andrea ; Filaci, Gilberto ; Fenoglio, Daniela.

In: AIDS (London, England), Vol. 28, No. 7, 24.04.2014, p. 1071-1074.

Research output: Contribution to journal › Article › peer-review

Dentone, Chiara ; Di Biagio, Antonio ; Parodi, Alessia ; Bozzano, Federica ; Fraccaro, Paolo ; Signori, Alessio ; Cenderello, Giovanni ; Mantia, Eugenio ; Orofino, Giancarlo ; De Maria, Andrea ; Filaci, Gilberto ; Fenoglio, Daniela. / Innate immunity cell activation in virologically suppressed HIV-infected maraviroc-treated patients. In: AIDS (London, England). 2014 ; Vol. 28, No. 7. pp. 1071-1074.

@article{e7d37ca72b2040d1a2ca92a2ce5a2823,

title = "Innate immunity cell activation in virologically suppressed HIV-infected maraviroc-treated patients",

abstract = "This is a cross-sectional, case-control study analyzing the effect of antiretroviral therapy (ART) including or not maraviroc, on circulating monocytes and natural killer cells. Sixty-eight HIV-positive patients virologically suppressed receiving ART at least 6 months were subdivided as receiving (group 1) or not (group 2) maraviroc in their ART. Frequency of monocytes and natural killer cells, as well as their activation markers, were studied. Modulation of innate immune cells may be differently affected by combined ART.",

author = "Chiara Dentone and {Di Biagio}, Antonio and Alessia Parodi and Federica Bozzano and Paolo Fraccaro and Alessio Signori and Giovanni Cenderello and Eugenio Mantia and Giancarlo Orofino and {De Maria}, Andrea and Gilberto Filaci and Daniela Fenoglio",

year = "2014",

month = apr,

day = "24",

doi = "10.1097/QAD.0000000000000194",

language = "English",

volume = "28",

pages = "1071--1074",

journal = "AIDS",

issn = "0269-9370",

publisher = "NLM (Medline)",

number = "7",

}

TY - JOUR

T1 - Innate immunity cell activation in virologically suppressed HIV-infected maraviroc-treated patients

AU - Dentone, Chiara

AU - Di Biagio, Antonio

AU - Parodi, Alessia

AU - Bozzano, Federica

AU - Fraccaro, Paolo

AU - Signori, Alessio

AU - Cenderello, Giovanni

AU - Mantia, Eugenio

AU - Orofino, Giancarlo

AU - De Maria, Andrea

AU - Filaci, Gilberto

AU - Fenoglio, Daniela

PY - 2014/4/24

Y1 - 2014/4/24

N2 - This is a cross-sectional, case-control study analyzing the effect of antiretroviral therapy (ART) including or not maraviroc, on circulating monocytes and natural killer cells. Sixty-eight HIV-positive patients virologically suppressed receiving ART at least 6 months were subdivided as receiving (group 1) or not (group 2) maraviroc in their ART. Frequency of monocytes and natural killer cells, as well as their activation markers, were studied. Modulation of innate immune cells may be differently affected by combined ART.

AB - This is a cross-sectional, case-control study analyzing the effect of antiretroviral therapy (ART) including or not maraviroc, on circulating monocytes and natural killer cells. Sixty-eight HIV-positive patients virologically suppressed receiving ART at least 6 months were subdivided as receiving (group 1) or not (group 2) maraviroc in their ART. Frequency of monocytes and natural killer cells, as well as their activation markers, were studied. Modulation of innate immune cells may be differently affected by combined ART.

UR - http://www.scopus.com/inward/record.url?scp=84897490401&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897490401&partnerID=8YFLogxK

U2 - 10.1097/QAD.0000000000000194

DO - 10.1097/QAD.0000000000000194

M3 - Article

C2 - 24499952

AN - SCOPUS:84897490401

VL - 28

SP - 1071

EP - 1074

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 7

ER -